研究简报

2,6,6-三甲基-双环[3,1,1]庚基-3-(4-芳基-2-噻唑)腙类化合物的合成及其抑菌和抗肿瘤活性研究

  • 鲍名凯 ,
  • 杨益琴 ,
  • 谷文 ,
  • 徐徐 ,
  • 曹明珍 ,
  • 王石发
展开
  • a. 南京林业大学化学工程学院 南京 210037;
    b. 南京林业大学轻工科学与工程学院 南京 210037;
    c. 江苏省生物质绿色燃料与化学品重点实验室 南京 210037

收稿日期: 2014-04-26

  修回日期: 2014-05-22

  网络出版日期: 2014-06-11

基金资助

国家自然科学基金(No. 31170538)、江苏省教育厅优势学科经费(No. 201104015)资助项目.

Synthesis and Antibacterial, Antitumor Activity of 2,6,6-Thrimethyl- bicyclo[3,1,1]heptan-3-(4-aryl-2-thiazoyl)hydrazones

  • Bao Mingkai ,
  • Yang Yiqing ,
  • Gu Wen ,
  • Xu Xu ,
  • Cao Mingzhen ,
  • Wang Shifa
Expand
  • a. College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037;
    b. College of Light Industry and Engineering, Nanjing Forestry University, Nanjing 210037;
    c. Jiangsu Key Laboratory of Biomass-based Green Fuels and Chemicals, Nanjing 210037

Received date: 2014-04-26

  Revised date: 2014-05-22

  Online published: 2014-06-11

Supported by

Project supported by the National Natural Science Foundation of China (No. 31170538) and the Forestry Public Sector Research Found of State Forestry Administration of China (No. 201104015)

摘要

以α-蒎烯为起始原料,经加成、氧化、缩合制得中间体,继而与α-溴代芳基乙酮在常温下反应合成12个新型2,6,6-三甲基-双环[3,1,1]庚基-3-(4-芳基-2-噻唑)腙类化合物,产率达52.4%~88.9%. 其结构经1H NMR,13C NMR,IR,LC/MS和元素分析进行了确证. 初步生物活性测试结果表明:部分目标化合物具有较好的抑菌活性和一定的抗肿瘤活性.

本文引用格式

鲍名凯 , 杨益琴 , 谷文 , 徐徐 , 曹明珍 , 王石发 . 2,6,6-三甲基-双环[3,1,1]庚基-3-(4-芳基-2-噻唑)腙类化合物的合成及其抑菌和抗肿瘤活性研究[J]. 有机化学, 2014 , 34(10) : 2146 -2151 . DOI: 10.6023/cjoc201404049

Abstract

Twelve new 2,6,6-thrimethyl-bicyclo[3,1,1]heptan-3-(4-aryl-2-thiazoyl)hydrazones were synthesized by using α-pinene as starting material in four steps reaction including addition, oxidation, condensation, and reaction with α-bromo- acetophenone under room temperature. The yields of products were in the range from 52.4% to 88.9%. All synthesized new compounds were confirmed by 1H NMR, 13C NMR, IR, LC/MS spectra and elemental analysis. The preliminary bioassay showed that some of the target compounds exhibited significant antibacterial activity and certain antitumor activity.

参考文献

[1] Khare, M.; Keady, D. Expert Opin. Pharm. 2003, 4, 165
[2] Vicini, P.; Geroniki, A.; Anastasia, K. Bioorg. Med. Chem. 2006, 14, 3859.
[3] Bell, F. W.; Cantrell, A. S.; Hoegberg, M. J. Med. Chem. 1995, 38, 4929
[4] Sharma, P. K.; Sawheny, S. N. Bioorg. Med. Chem. Lett. 1997, 7, 2427.
[5] Vicini, P.; Geronikakib, A.; Incertia, M. Bioorg. Med. Chem. 2003, 11, 4785.
[6] Lu, Y. Y.; Li, C. M.; Wang, Z. J. Med. Chem. 2009, 52, 1701.
[7] Turan, G. Z.; Kaplancikli, A.; Yildiz, M. T.; Chevallet, P.; Kaya, D. Eur. J. Med. Chem. 2005, 40, 607.
[8] Cukurovali, A.; Yilmaz, I.; Gur, S.; Kazaz, C. Eur. J. Med. Chem. 2006, 41, 201.
[9] Shi, H. B.; Zhang, S. J.; Ge, Q. F.; Guo, D. W.; Cai, C. M.; Hu, W. X. Bioorg. Med. Chem. Lett. 2010, 20, 6555.
[10] Khan, S. A. Eur. J. Med. Chem. 2008, 43, 2040.
[11] Merlani, M. I.; Amiranashvili, L. S.; Mulkidzhanyan, K. G.; Shelar, A. R.; Manvi, F. V. Chem. Nat. Compd. 2008, 44, 618.
[12] Iványi, Z.; Wölfling, J.; Görbe, T.; Szécsi, M.; Wittmann, T.; Schneider, G. Steroids 2010, 75, 450.
[13] Bizzarri, B.; Chimenti, F.; Secci, D.; Bolsaco, A. Granese, A. Bioorg. Med. Chem. 2007, 17, 4635.
[14] Gulhan, T. Z.; Ahmet, O.; Zafer, A. K.; Kadriye, B.; Pierre, C.; Gulsen, A. Eur. J. Med. Chem. 2008, 43, 981.
[15] Caputto, M. E.; Ciccarelli, A.; Frank, F.; Moglioni, A. G. Eur. J. Med. Chem. 2012, 35, 155.
[16] Yuan, M. Y.; Liu, W. H.; Zhang, Y, Q.; Yan, H. F.; Zhang, D. N.; Liu, H. M.; Wang, J. P. Chin. J. Org. Chem. 2013, 33, 1108 (in Chinese).
(袁明月, 刘伟华, 张英群, 闫红飞, 张冬暖, 刘卉闵, 王建平, 有机化学, 2013, 33, 1108.)
[17] Wang, S. F.; Li, Y. P.; Zhang M. G. J. Org. Chem. 2007, 27, 1612 (in Chinese).
(王石发, 李艳苹, 张明光, 有机化学, 2007, 27, 1612.)

文章导航

/

〈 〉